Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palmoplantar Pustular Psoriasis”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Testing effectiveness (Phase 2)Ended earlyNCT01197989
What this trial is testing

Efficacy Study of TEPSO® Socks in Improving Palmoplantar Pustulosis

Who this might be right for
Pustulosis of Palms and Soles
Lenzi Egisto S.P.A. 17
Large-scale testing (Phase 3)Study completedNCT02641730
What this trial is testing

An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Janssen Pharmaceutical K.K. 159
Large-scale testing (Phase 3)Looking for participantsNCT07219420
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
UCB Biopharma SRL 320
Not applicableLooking for participantsNCT07545902
What this trial is testing

Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis

Who this might be right for
Plaque Type PsorisisNon-pustular Palmoplantar Psoriasis
ICIM International S.r.l. 35
Not applicableUnknownNCT04566471
What this trial is testing

Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence

Who this might be right for
Palmoplantar PustulosisGeneralized Pustular Psoriasis
Peking University Third Hospital 200
Not applicableLooking for participantsNCT04359394
What this trial is testing

International Rare And Severe Psoriasis Expert Network

Who this might be right for
Pustular Psoriasis (PP)
University Hospital, Basel, Switzerland 180
Large-scale testing (Phase 3)Study completedNCT05174065
What this trial is testing

Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Amgen 176
Testing effectiveness (Phase 2)Study completedNCT04015518
What this trial is testing

Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Boehringer Ingelheim 152
Post-approval studies (Phase 4)Ended earlyNCT06042920
What this trial is testing

Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

Who this might be right for
Palmoplantar PsoriasisGenital Psoriasis
Bristol-Myers Squibb 130
Testing effectiveness (Phase 2)Ended earlyNCT05194839
What this trial is testing

A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)

Who this might be right for
Palmoplantar Pustulosis
Aristea Therapeutics, Inc. 79
Large-scale testing (Phase 3)Study completedNCT00686686
What this trial is testing

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED)

Who this might be right for
Psoriasis
Merck Sharp & Dohme LLC 23
Large-scale testing (Phase 3)Study completedNCT04451720
What this trial is testing

Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
AbbVie 119
Large-scale testing (Phase 3)Study completedNCT02008890
What this trial is testing

Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab

Who this might be right for
Palmoplantar Pustular Psoriasis
Novartis Pharmaceuticals 237
Post-approval studies (Phase 4)Ended earlyNCT05710185
What this trial is testing

Deucravacitinib for the Treatment of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Brigham and Women's Hospital 3
Testing effectiveness (Phase 2)Study completedNCT01794117
What this trial is testing

Anakinra for Inflammatory Pustular Skin Diseases

Who this might be right for
Sneddon-WilkinsonAcrodermatitis Continua of HallopeauPustular Psoriasis+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 18
Not applicableEnded earlyNCT07000630
What this trial is testing

Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
Peking University First Hospital 3
Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Who this might be right for
Psoriasis
AbbVie 174
Large-scale testing (Phase 3)Not Yet RecruitingNCT07530367
What this trial is testing

Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis (PPP)
Second Affiliated Hospital, Zhejiang University, School of Medicine 135
Large-scale testing (Phase 3)Study completedNCT00353119
What this trial is testing

A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis

Who this might be right for
Palmoplantaris Pustulosis
Innovaderm Research Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07013201
What this trial is testing

A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

Who this might be right for
Palmoplantar Pustulosis
LEO Pharma 135
Next Page